VinFast is set to make its India debut at the 2025 Bharat Mobility Expo, showcasing its first India-specific electric vehicle alongside global models like the VF e34 and VF7 SUVs. Recent road tests of VinFast vehicles in India have sparked curiosity, offering a preview of their modern features and sleek design.

The Vietnamese EV manufacturer is also planning to establish a manufacturing facility near Chennai, demonstrating its commitment to India’s fast-expanding EV market. With its strategic approach, VinFast aims to provide innovative mobility solutions and position itself as a key player in the country’s electric vehicle segment.

VinFast is gearing up to make its mark in India with the launch of the VF e34, a compact electric SUV aimed at the growing EV market. Powered by a 110kW motor, the SUV offers a top speed of 130 km/h and a practical range of up to 318 km, thanks to its 41.9kWh battery. The VF e34 also features fast-charging capabilities, allowing a 10% to 70% charge in just 27 minutes. Positioned to rival models like the Maruti Suzuki eVitara and Hyundai Creta EV, the VF e34 blends global recognition with advanced features, making it a strong contender in India’s competitive EV landscape.

Scheduled from January 17 to 22, 2025, the Bharat Mobility Global Expo will take place across three major venues in the Delhi NCR region—Bharat Mandapam in New Delhi, Yashobhoomi in Dwarka, and the India Expo Centre & Mart in Greater Noida. This highly anticipated event will bring together leading domestic and international companies, showcasing a wide range of vehicles powered by electric, hybrid, CNG, and biofuel technologies. With a focus on sustainable innovation, the expo aims to highlight cutting-edge advancements that are shaping the future of mobility.

Mumbai, Dec 30: The Indian stock market closed in the red on Monday as a spike in volatility amid foreign institutional investors’ (FIIs) outflow and global cues affected investor sentiment.

Sensex ended at 78,248.13, down by 450.94 points or 0.57 per cent and Nifty settled at 23,644.9, down by 168.50 points or 0.71 per cent. Nifty Bank ended at 50,952.75, down by 358.55 points, or 0.70 per cent.

The Nifty Midcap 100 index closed at 57,189.75 after rising 209.95 points, or 0.37 per cent, while the Nifty Smallcap 100 index closed at 18,639.95 after declining 115.90 points, or 0.62 per cent.

According to Rupak De of LKP Securities, “Nifty remained volatile during the session, oscillating between 23,600 and 23,900. On the daily chart, the index has slipped below its recent consolidation.”

“Additionally, it continues to trade below the 200-DMA, indicating weak sentiment. The overall outlook remains negative for the short term, with potential downside risks,” he noted.

On the Bombay Stock Exchange (BSE), 1,486 shares ended in green and 2,636 shares in red, whereas there was no change in 145 shares.

On the sectoral front, PSU Bank, auto, financial service, metal, realty, media, energy, infra and commodities sectors were major gainers. Pharma, IT, FMCG and healthcare sectors were major losers.

In the Sensex pack, Tata Motors, Titan, M&M, Tata Steel, SBI, NTPC, Maruti Suzuki, HDFC Bank and ICICI Bank were the top losers. While Zomato, Tech Mahindra, HCL Tech, Sun Pharma, IndusInd Bank and Asian Paints were the top gainers.

The rupee closed flat at 84.84 against the US dollar, down nearly 30 paisa form its previous closing at 84.54 rupee against dollar.

On Monday, the Indian currency opened at 85.48 against the dollar after strengthening by 6 paise.

FIIs sold equities worth Rs 1,323.29 crore on December 27, while domestic institutional investors bought equities worth Rs 2,544.64 crore on the same day.

New Delhi, December 30: With artificial intelligence (AI) reshaping healthcare at an unprecedented pace, the All India Institute of Medical Sciences (AIIMS), New Delhi is investing more than Rs 300 crore in developing digital infrastructure, said Director Dr. M. Srinivas.

He said this at a meeting held at the national capital deliberating the transformative potential of AI in revolutionising health awareness and patient education empowerment.

Leaders in healthcare, technology, and policy shared insights into how AI is poised to bridge critical gaps in health communication, making information more accessible, reliable, and patient-centric.

“AI is revolutionising everything from patient care to health communication,” said Dr. M. Srinivas, Director of AIIMS.

“We are investing over Rs 300 crore in digital infrastructure to ensure that every stakeholder — patients, doctors, and researchers — benefits from this innovation. By integrating AI, we can improve efficiency, reduce delays, and enable world-class research,” he added.

The experts at AIIMS also stressed the need to bridge the gap of misinformation by delivering accurate, easily understandable, and personalised healthcare information via AI to people across diverse demographics.

Srinivas also emphasised that leveraging AI to simplify and disseminate health information will empower patients and improve their engagement with healthcare systems, ultimately leading to better health outcomes.

“A good health system isn’t reliant on individuals. AI can play a vital role in making healthcare more accurate, compassionate, and equitable,” Dr. Kavita Narayan, Senior Technical Advisor, HRH for Health Systems at the Ministry of Health and Family Welfare.

“To truly make a difference, we must integrate technology thoughtfully and ensure collaboration between policymakers, technologists, and healthcare providers,” she added.

The experts also caution against overdependence on technology at the expense of human connection.

K.P. Kochhar, Professor and Head of the Physiology Department at AIIMS, stressed the importance of balancing innovation with empathy in healthcare.

“While AI can enhance precision and efficiency, we must preserve the human touch in healthcare. Compassion and technology must work together to create systems that prioritise the well-being of patients,” Kochhar said.